                               SEQUENCE LISTING

<110> CARMOT THERAPEUTICS, INC.
 
<120> MODULATORS OF G-PROTEIN COUPLED RECEPTORS

<130> 41517-0007WO1

<140> PCT/US2022/029305
<141> 2022-05-13

<150> 63/188,342
<151> 2021-05-13

<160> 68    

<170> PatentIn version 3.5

<210> 1
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (4)..(43)
<223> Any amino acid

<220>
<221> SITE
<222> (4)..(43)
<223> This region may encompass 30-40 residues

<220>
<221> MOD_RES
<222> (44)..(44)
<223> Any amino acid, amino ester, or amino acid amide that is
      optionally substituted with from 1-2 modifying groups

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 1
Gly Thr Phe Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  


<210> 2
<211> 47
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(20)
<223> Any amino acid

<220>
<221> SITE
<222> (1)..(20)
<223> This region may encompass 10-20 residues

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Modified amino acid

<220>
<221> MOD_RES
<222> (22)..(46)
<223> Any amino acid

<220>
<221> SITE
<222> (22)..(46)
<223> This region may encompass 15-25 residues

<220>
<221> MOD_RES
<222> (47)..(47)
<223> Any amino acid, amino ester, or amino acid amide that is
      optionally substituted with from 1-2 modifying groups

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 2
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45          


<210> 3
<211> 47
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(20)
<223> Any amino acid

<220>
<221> SITE
<222> (1)..(20)
<223> This region may encompass 10-20 residues

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Lysine with a modifying group selected from an acyl
      group and a PEG group and combinations thereof

<220>
<221> MOD_RES
<222> (22)..(46)
<223> Any amino acid

<220>
<221> SITE
<222> (22)..(46)
<223> This region may encompass 15-25 residues

<220>
<221> MOD_RES
<222> (47)..(47)
<223> Any amino acid, amino ester, or amino acid amide that is
      optionally substituted with from 1-2 modifying groups

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 3
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45          


<210> 4
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Phe, alpha-methyl-2-fluorophenylalaine, alpha-methyl-phenylalaine,
      or 2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Thr, Ala, or Val

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Tyr or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-tetraoxa-
      6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Tyr, alpha-methyl-leucine, or 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Lys, Ornithine, or Arg

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Gln, Ile, or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic
      acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ala or Gln

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid or (1S,28S)-1-amino-7,16,25,30-
      tetraoxo-9,12,18,21-tetraoxa-6,15,24,29-tetraazapentatetracontane-
      1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Val or Ile

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Asn, Gln, (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid, or D-Glutamic acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Trp or Tyr

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ile or Leu

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (37)..(37)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid or absent

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 4
Gly Thr Xaa Xaa Ser Asp Xaa Ser Ile Xaa Leu Asp Xaa Xaa Ala Xaa 
1               5                   10                  15      


Xaa Xaa Phe Xaa Xaa Xaa Leu Xaa Xaa Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser Xaa 
        35          


<210> 5
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Phe, alpha-methyl-2-fluorophenylalaine, alpha-methyl-phenylalaine,
      or 2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Thr, Ala, or Val

<220>
<221> MOD_RES
<222> (7)..(7)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Tyr, alpha-methyl-leucine, or 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Lys, Ornithine, or Arg

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Gln, Ile, or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic
      acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ala or Gln

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid or (1S,28S)-1-amino-7,16,25,30-
      tetraoxo-9,12,18,21-tetraoxa-6,15,24,29-tetraazapentatetracontane-
      1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Val or Ile

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Asn, Gln, (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid, or D-Glutamic acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Trp or Tyr

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ile or Leu

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (37)..(37)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid or absent

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 5
Gly Thr Xaa Xaa Ser Asp Xaa Ser Ile Xaa Leu Asp Xaa Xaa Ala Xaa 
1               5                   10                  15      


Xaa Xaa Phe Xaa Xaa Xaa Leu Xaa Xaa Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser Xaa 
        35          


<210> 6
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Phe, alpha-methyl-2-fluorophenylalaine, alpha-methyl-phenylalaine,
      or 2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Thr, Ala, or Val

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Tyr or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-tetraoxa-
      6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Tyr, alpha-methyl-leucine, or 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Lys, Ornithine, or Arg

<220>
<221> MOD_RES
<222> (14)..(14)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ala or Gln

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid or (1S,28S)-1-amino-7,16,25,30-
      tetraoxo-9,12,18,21-tetraoxa-6,15,24,29-tetraazapentatetracontane-
      1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Val or Ile

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Asn, Gln, (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid, or D-Glutamic acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Trp or Tyr

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ile or Leu

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (37)..(37)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid or absent

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 6
Gly Thr Xaa Xaa Ser Asp Xaa Ser Ile Xaa Leu Asp Xaa Xaa Ala Xaa 
1               5                   10                  15      


Xaa Xaa Phe Xaa Xaa Xaa Leu Xaa Xaa Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser Xaa 
        35          


<210> 7
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Phe, alpha-methyl-2-fluorophenylalaine, alpha-methyl-phenylalaine,
      or 2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Thr, Ala, or Val

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Tyr or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-tetraoxa-
      6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Tyr, alpha-methyl-leucine, or 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Lys, Ornithine, or Arg

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Gln, Ile, or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic
      acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ala or Gln

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Val or Ile

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Asn, Gln, (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid, or D-Glutamic acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Trp or Tyr

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ile or Leu

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (37)..(37)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid or absent

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 7
Gly Thr Xaa Xaa Ser Asp Xaa Ser Ile Xaa Leu Asp Xaa Xaa Ala Xaa 
1               5                   10                  15      


Xaa Xaa Phe Xaa Xaa Xaa Leu Xaa Xaa Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser Xaa 
        35          


<210> 8
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Phe, alpha-methyl-2-fluorophenylalaine, alpha-methyl-phenylalaine,
      or 2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Thr, Ala, or Val

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Tyr or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-tetraoxa-
      6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Tyr, alpha-methyl-leucine, or 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Lys, Ornithine, or Arg

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Gln, Ile, or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic
      acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ala or Gln

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid or (1S,28S)-1-amino-7,16,25,30-
      tetraoxo-9,12,18,21-tetraoxa-6,15,24,29-tetraazapentatetracontane-
      1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Val or Ile

<220>
<221> MOD_RES
<222> (21)..(21)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Trp or Tyr

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ile or Leu

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (37)..(37)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid or absent

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 8
Gly Thr Xaa Xaa Ser Asp Xaa Ser Ile Xaa Leu Asp Xaa Xaa Ala Xaa 
1               5                   10                  15      


Xaa Xaa Phe Xaa Xaa Xaa Leu Xaa Xaa Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser Xaa 
        35          


<210> 9
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Phe, alpha-methyl-2-fluorophenylalaine, alpha-methyl-phenylalaine,
      or 2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Thr, Ala, or Val

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Tyr or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-tetraoxa-
      6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Tyr, alpha-methyl-leucine, or 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Lys, Ornithine, or Arg

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Gln, Ile, or (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-tricarboxylic
      acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ala or Gln

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid or (1S,28S)-1-amino-7,16,25,30-
      tetraoxo-9,12,18,21-tetraoxa-6,15,24,29-tetraazapentatetracontane-
      1,28,45-tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Val or Ile

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Asn, Gln, (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid, or D-Glutamic acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Trp or Tyr

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ile or Leu

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Ala or Glu

<220>
<221> MOD_RES
<222> (37)..(37)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 9
Gly Thr Xaa Xaa Ser Asp Xaa Ser Ile Xaa Leu Asp Xaa Xaa Ala Xaa 
1               5                   10                  15      


Xaa Xaa Phe Xaa Xaa Xaa Leu Xaa Xaa Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser Xaa 
        35          


<210> 10
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 10
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 11
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Phe or alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 11
Gly Thr Xaa Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly 
            20                  25      


<210> 12
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 12
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Arg Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 13
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 13
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Arg Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 14
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> alpha-methyl-phenylalaine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 14
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Arg Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 15
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> 2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 15
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Arg Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 16
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 16
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 17
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 17
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 18
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 18
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Glu Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 19
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 19
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Gln Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 20
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (37)..(37)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 20
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Gln Ala Ala 
1               5                   10                  15      


Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser Xaa 
        35          


<210> 21
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 21
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Ala 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 22
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 22
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Gln Ala Ala 
1               5                   10                  15      


Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 23
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 23
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Asn Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 24
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 24
Gly Thr Phe Val Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 25
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 25
Gly Thr Phe Ala Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 26
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (7)..(7)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid

<400> 26
Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys Gln Ala Ala 
1               5                   10                  15      


Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 27
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 27
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 28
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (37)..(37)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 28
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Gln Ala Ala 
1               5                   10                  15      


Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser Xaa 
        35          


<210> 29
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (7)..(7)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid

<400> 29
Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys Gln Ala Ala 
1               5                   10                  15      


Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 30
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 30
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly 
            20                  25      


<210> 31
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 31
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly 
            20                  25      


<210> 32
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> alpha-methyl-leucine

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Ornithine

<220>
<221> MOD_RES
<222> (14)..(14)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (21)..(21)
<223> D-Glutamic acid

<400> 32
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Leu Leu Asp Xaa Xaa Ala Gln 
1               5                   10                  15      


Xaa Glu Phe Ile Glu Tyr Leu Ile Glu Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 33
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (10)..(10)
<223> alpha-methyl-leucine

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Ornithine

<220>
<221> MOD_RES
<222> (14)..(14)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (21)..(21)
<223> D-Glutamic acid

<400> 33
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Leu Leu Asp Xaa Xaa Ala Gln 
1               5                   10                  15      


Xaa Glu Phe Ile Glu Tyr Leu Ile Glu Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 34
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 34
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 35
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 35
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala Gln 
1               5                   10                  15      


Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 36
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (14)..(14)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid

<400> 36
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Xaa Ala Ala 
1               5                   10                  15      


Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 37
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (17)..(17)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (21)..(21)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 37
Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Gln Ala Ala 
1               5                   10                  15      


Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210> 38
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 38
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 39
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 39
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Arg Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 40
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 40
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Arg Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 41
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> alpha-methyl-phenylalaine

<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 41
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Arg Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 42
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> 2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 42
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Arg Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 43
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 43
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 44
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 44
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 45
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 45
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Glu Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 46
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 46
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Gln Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 47
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (18)..(18)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (38)..(38)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 47
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Gln Ala 
1               5                   10                  15      


Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser Xaa 
        35              


<210> 48
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 48
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Ala Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 49
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 49
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Gln Ala 
1               5                   10                  15      


Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 50
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 50
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Asn Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 51
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 51
Glu Gly Thr Phe Val Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 52
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 52
Glu Gly Thr Phe Ala Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 53
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (8)..(8)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> 2-aminoisobutyric acid

<400> 53
Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys Gln Ala 
1               5                   10                  15      


Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 54
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 54
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 55
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 55
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 56
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (18)..(18)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (38)..(38)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 56
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Gln Ala 
1               5                   10                  15      


Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser Xaa 
        35              


<210> 57
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (8)..(8)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> 2-aminoisobutyric acid

<400> 57
Glu Gly Thr Phe Thr Ser Asp Xaa Ser Ile Tyr Leu Asp Lys Gln Ala 
1               5                   10                  15      


Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 58
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 58
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly 
            20                  25          


<210> 59
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 59
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly 
            20                  25          


<210> 60
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> alpha-methyl-leucine

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Ornithine

<220>
<221> MOD_RES
<222> (15)..(15)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> D-Glutamic acid

<400> 60
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Leu Leu Asp Xaa Xaa Ala 
1               5                   10                  15      


Gln Xaa Glu Phe Ile Glu Tyr Leu Ile Glu Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 61
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> alpha-methyl-2-fluorophenylalaine

<220>
<221> MOD_RES
<222> (11)..(11)
<223> alpha-methyl-leucine

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Ornithine

<220>
<221> MOD_RES
<222> (15)..(15)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> D-Glutamic acid

<400> 61
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Leu Leu Asp Xaa Xaa Ala 
1               5                   10                  15      


Gln Xaa Glu Phe Ile Glu Tyr Leu Ile Glu Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 62
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazaoctatetracontane-1,28,48-
      tricarboxylic acid

<400> 62
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 63
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (3S,8S,13S,22S)-22-amino-1-((1r,4S)-4-((18-
      carboxyoctadecanamido)methyl)cyclohexyl)-1,6,11,16-
      tetraoxo-2,7,12,17-tetraazadocosane-3,8,13,22-
      tetracarboxylic acid

<400> 63
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 64
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> D-Aspartic acid

<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 64
Asp Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 65
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazaoctatetracontane-1,28,48-
      tricarboxylic acid

<400> 65
Asp Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 66
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> D-Glutamic acid

<220>
<221> MOD_RES
<222> (11)..(11)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazaoctatetracontane-1,28,48-
      tricarboxylic acid

<400> 66
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Xaa Leu Asp Lys Ile Ala 
1               5                   10                  15      


Gln Xaa Ala Phe Val Gln Trp Leu Ile Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 67
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (15)..(15)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> 2-aminoisobutyric acid

<400> 67
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Xaa Ala 
1               5                   10                  15      


Ala Xaa Glu Phe Val Asn Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210> 68
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (18)..(18)
<223> 2-aminoisobutyric acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> (1S,28S)-1-amino-7,16,25,30-tetraoxo-9,12,18,21-
      tetraoxa-6,15,24,29-tetraazapentatetracontane-1,28,45-
      tricarboxylic acid

<400> 68
Glu Gly Thr Phe Thr Ser Asp Tyr Ser Ile Tyr Leu Asp Lys Gln Ala 
1               5                   10                  15      


Ala Xaa Glu Phe Val Xaa Trp Leu Leu Ala Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


